Micropep’s New CEO Georg Goeres Plans to Propel Global Expansion
22 July 2025 
Georg Goeres
When Georg Goeres stepped into the role of CEO at Micropep, he didn’t just bring a résumé stacked with big-ag experience. He brought a vision for translating cutting-edge peptide science into commercial reality. With more than two decades in the agriculture sector, including senior roles at Syngenta and Indigo Ag, Goeres has become known as a strategic operator with a knack for bridging R&D and revenue. Now, he’s putting that expertise to work guiding Micropep through its most transformative chapter yet.
From Corporate Roots to Startup Agility
Goeres’ path to Micropep started in an unlikely place: banking. His early work in M&A and venture capital laid a foundation for strategic thinking, which he later applied to various roles at Syngenta, including seed treatment during the contentious phase-out of neonicotinoids in Europe.
“These moments teach you how to pivot when the rules of the game change — something that’s all too common in agriculture,” Goeres said.
His time at Indigo Ag sharpened those instincts further. There, he helped build the European division from scratch and later took global responsibility for the biologicals business unit. Along the way, he learned the value of choosing the right partners and understanding market fit.
“Sometimes it’s not the biggest distributor that gets your results. It’s the one who believes in your product and makes it central to their offering,” said Goeres.
Innovation, Validation and Transformation
As Micropep prepares to launch its first product, a peptide-based fungicide currently known as MPD01, Goeres is focused on three strategic pillars: platform innovation, product validation, and organizational transformation.
First up is Krisalix, the company’s AI-powered discovery engine. With partnerships already in place with industry heavyweights like Corteva and FMC, Goeres views Krysalix as more than a research tool — it’s the company’s long-term growth engine.
“Krisalix lets us move from molecule discovery to development-ready candidates faster and more precisely than traditional pipelines,” Goeres said. “It’s not just about speed. It’s about designing peptides that are scalable and cost-effective from day one.”
Then there’s MPD01 itself — a proof-of-concept product targeting soybean rust and powdery mildew. Field trials and commercial testing are already underway in South America, with regulatory dossier submissions planned for early 2026. The goal, Goeres said, is to demonstrate that peptides can be more than niche, offering real efficacy without the residue or ecotoxicity concerns of traditional chemistry.
Finally, there’s the people side of the business.
“We’re evolving from a research-focused startup into a commercial organization,” Goeres said. “That means hiring the right people, building partner-facing capabilities, and aligning the entire company around delivering solutions, not just science.”
Deep Tech, Big Challenges
Navigating today’s regulatory and investment landscape isn’t for the faint of heart, especially in ag tech. But Micropep is well-positioned, having raised $40 million in its Series B just under a year ago.
“We’re not under pressure to raise [funding] again immediately, but we’ll do so proactively,” Goeres said. “This is about keeping the momentum, not scrambling for survival.”
Despite a tough funding climate, he remains bullish on the sector. Biologicals are expected to outpace traditional ag chem with growth forecasts ranging from 12% to 14% CAGR — compared to 3% to 5% for synthetics. For Goeres, that means the future is wide open, provided companies can survive the short-term headwinds.
“I want to see more companies succeed — not fewer. When a startup with a good technology fails, it’s a loss for everyone, especially farmers who need more choices, not less,” Goeres said.
The Science, the Market
With Goeres at the helm, Micropep is betting that its peptides — and its platform — can carve out a new category in crop protection. But success, he says, won’t just come from science.
“It’s not enough to have a breakthrough molecule,” Goeres said. “You need a breakthrough mindset — one that connects innovation to the farmgate.”
And with Goeres leading the charge, Micropep is aiming to do exactly that.
Get The Newsletter Today!
